School of Medicine
Showing 4,361-4,380 of 5,027 Results
-
Juwono L. Sutedjo, MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sutedjo is a board-certified, fellowship-trained cardiologist. She is a faculty in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Sutedjo holds seven board certifications. She specializes in complex cardiovascular conditions, emphasizing multimodality cardiovascular imaging and disease prevention. She integrates leading-edge diagnostics with evidence-based strategies to provide comprehensive, patient-centered care. She has led multidisciplinary clinics, telehealth programs, and ambulatory operations to enhance accessibility and efficiency.
Dr. Sutedjo has a visionary approach to the future of cardiovascular medicine, particularly in the context of the rapidly evolving digital era. With a clear understanding of the need for innovative business models in healthcare, she pursued an MBA from the Wharton School of the University of Pennsylvania to complement her medical expertise. As a physician executive and clinical researcher, she has deep expertise in clinical operations, health care delivery, and finance. Her diverse background spans private practice, integrated healthcare systems, and managed care settings, providing her with a comprehensive perspective on the healthcare landscape. Driven by a commitment to enhancing patient outcomes, Dr. Sutedjo is deeply invested in leveraging digital health innovations and artificial intelligence to advance the field of cardiovascular care.
Dr. Sutedjo’s research explores AI, machine learning, and digital health applications in cardiovascular risk prediction, diagnosis, and treatment. She aims to improve efficiency, reduce disparities, and enhance precision in clinical decision-making.
Dr. Sutedjo has published her work in Circulation, The American Journal of Medicine, and 21st Century Cardiology. She has also presented at the American Heart Association Scientific Sessions and other national and international conferences, engaging with industry leaders and private sector stakeholders on the role of AI in health care. She has co-founded several health technology startups and served as a consultant for leading technology companies and private sector organizations. Additionally, she played a key role in the IPO of a tech startup on the Toronto Stock Exchange. -
David Svec, MD, MBA
Clinical Associate Professor, Medicine
Current Research and Scholarly InterestsHigh Value Care: Leading quality improvement projects / research initiatives
-
Katrin J Svensson
Associate Professor of Pathology
Current Research and Scholarly InterestsMolecular metabolism
Protein biochemistry
Cell biology and function
Animal physiology -
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Andrew Sweatt
Assistant Professor of Medicine (PACCM)
Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.
-
Susan M. Swetter, MD
Mosbacher Professor of Dermatology
Current Research and Scholarly Interests1) Early detection of melanoma through precision screening, novel imaging technologies (including AI), and professional/public education to raise awareness. 2) Therapeutic prevention of melanoma in high-risk groups. 3) Epidemiologic and sociodemographic melanoma risk factor identification. 4) Co-Founder/Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control; Founding Director of the Wipe Out Melanoma - California initiative.
-
Ali Bin Syed
Clinical Associate Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Medical Director of Pediatric MRI at Stanford. Dr. Syed has received subspecialty training in adult body imaging, pediatric body imaging, congenital cardiac imaging, and musculoskeletal imaging. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher and works with engineers and scientists to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.
-
Karl G. Sylvester
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsScholarly interests include investigation of molecular markers of human disease that provide diagnostic function, serve as targets for possible therapeutic manipulation, or provide insight into mechanisms of human disease. Specific diseases of interest include common conditions of pregnancy, gut microbial ecology and Necrotizing Enterocolitis (NEC).
-
Gregory Arthur Szalkowski
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsWorkflow automation, radiotherapy quality assurance, machine learning
-
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology), Emeritus
Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections
-
Christopher N. Ta, MD
Professor of Ophthalmology
BioChristopher N. Ta, MD specializes in the diagnosis and medical treatment of cornea diseases. His areas of expertise are in the treatment of ocular infections, inflammation, and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta also has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
-
Meg Tabaka, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tabaka is a board-certified family medicine physician with a special focus in LGBTQ+ and underserved medicine. She is also a clinical assistant professor in the Division of Primary Care and Population Health of Stanford Department of Medicine. In this role, she splits her time between the Stanford Los Altos LGBTQ+ Primary Care Clinic and the MayView Community Clinic, a Federally Qualified Health Center in Mountain View, CA.
Dr. Tabaka provides expert, compassionate care personalized to each patient she serves. She is dedicated to meeting the health care needs of all of her patients including all members of the LGBTQ+ community and she welcomes patients of all ages and backgrounds to her practice.
Prior to her medical training, Dr. Tabaka completed her Masters in Public Health at the University of Minnesota. She went to complete medical school at Stanford University and completed residency at the Stanford O’Connor Family Medicine Residency Program in San Jose, CA.
